TradingMarkets’ 11 Stocks You Need To Know About This Morning
AtheroGenix
(
AGIX |
Quote |
Chart |
News |
PowerRating) reported positive results for its anti-atherosclerosis
drug.
Valero
(
VLO |
Quote |
Chart |
News |
PowerRating) guided higher for Q3.
Impax Labs
(
IPXL |
Quote |
Chart |
News |
PowerRating) said the FDA gave final approval for its
generic version of OxyContin.
Nabi Biopharmaceuticals
(
NABI |
Quote |
Chart |
News |
PowerRating) announced positive Phase II
results for NicVax, used to treat nicotine addiction.
Starbucks
(
SBUX |
Quote |
Chart |
News |
PowerRating) will raise prices 11 cents a cup, on average,
beginning October 6.
Pepsi Bottling
(
PBG |
Quote |
Chart |
News |
PowerRating) beat by a penny.
Lowe’s
(
LOW |
Quote |
Chart |
News |
PowerRating) said Q3 should beat forecasts.
Devon Energy
(
DVN |
Quote |
Chart |
News |
PowerRating) will split its shares 2:1 and will buy back up
to 10% of its stock.
Drexler Technologies
(
DRXR |
Quote |
Chart |
News |
PowerRating) received a $5 million order from the
Dept. of Homeland Security for its LaserCard optical memory cards.
Dell
(
DELL |
Quote |
Chart |
News |
PowerRating) said it saw no reason to change its Q3 guidance.
Solectron
(
SLR |
Quote |
Chart |
News |
PowerRating) will report after the bell; estimates are 0.04.